| Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort J González, ID Benítez, P Carmona, S Santisteve, A Monge, ... Chest 160 (1), 187-198, 2021 | 244 | 2021 |
| Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits AG Mathioudakis, W Janssens, P Sivapalan, A Singanayagam, ... Thorax 75 (6), 520-527, 2020 | 153 | 2020 |
| Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD N Soler, M Esperatti, S Ewig, A Huerta, C Agustí, A Torres European respiratory journal 40 (6), 1344-1353, 2012 | 146 | 2012 |
| Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease Z Matkovic, A Huerta, N Soler, R Domingo, A Gabarrús, A Torres, ... Respiration 84 (1), 17-26, 2012 | 143 | 2012 |
| Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics A Huerta, E Crisafulli, R Menéndez, R Martínez, N Soler, M Guerrero, ... Chest 144 (4), 1134-1142, 2013 | 134 | 2013 |
| Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: a long-term … M Guerrero, E Crisafulli, A Liapikou, A Huerta, A Gabarrús, A Chetta, ... PloS one 11 (3), e0150737, 2016 | 124 | 2016 |
| Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome Ò Miró, S Jiménez, A Mebazaa, Y Freund, G Burillo-Putze, A Martín, ... European heart journal 42 (33), 3127-3142, 2021 | 111 | 2021 |
| Frequency, risk factors, clinical characteristics, and outcomes of spontaneous pneumothorax in patients with coronavirus disease 2019: a case-control, emergency medicine-based … O Miro, P Llorens, S Jimenez, P Pinera, G Burillo-Putze, A Martin, ... Chest 159 (3), 1241-1255, 2021 | 104 | 2021 |
| Chronic obstructive pulmonary disease and COVID-19: interrelationships D Singh, AG Mathioudakis, A Higham Current opinion in pulmonary medicine 28 (2), 76-83, 2022 | 87 | 2022 |
| Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis MV Maddali, M Churpek, T Pham, E Rezoagli, H Zhuo, W Zhao, J He, ... The Lancet Respiratory Medicine 10 (4), 367-377, 2022 | 86 | 2022 |
| Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD E Crisafulli, R Menéndez, A Huerta, R Martinez, B Montull, E Clini, ... Chest 143 (4), 1009-1017, 2013 | 81 | 2013 |
| MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis A Navarro, RM Marrades, N Viñolas, A Quera, C Agustí, A Huerta, ... Oncology 76 (3), 162-169, 2009 | 77 | 2009 |
| Effect of a diagnostic strategy using an elevated and age-adjusted D-dimer threshold on thromboembolic events in emergency department patients with suspected pulmonary embolism … Y Freund, A Chauvin, S Jimenez, AL Philippon, S Curac, F Fémy, ... Jama 326 (21), 2141-2149, 2021 | 76 | 2021 |
| Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments US Ochoa, A Gil Emergencias 32, 233-241, 2020 | 76 | 2020 |
| Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study A Huerta, N Soler, M Esperatti, M Guerrero, R Menendez, A Gimeno, ... Respiratory research 15, 1-9, 2014 | 70 | 2014 |
| Pharmacological treatment of COVID-19: an opinion paper A García-Lledó, J Gómez-Pavón, JG del Castillo, ... Revista Española de Quimioterapia 35 (2), 115, 2022 | 69 | 2022 |
| What pulmonologists think about the asthma–COPD overlap syndrome M Miravitlles, B Alcázar, FJ Alvarez, T Bazús, M Calle, C Casanova, ... International journal of chronic obstructive pulmonary disease, 1321-1330, 2015 | 57 | 2015 |
| Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a … E Crisafulli, A Ielpo, E Barbeta, A Ceccato, A Huerta, A Gabarrús, N Soler, ... Respiratory research 19, 1-12, 2018 | 49 | 2018 |
| Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study J González, ID Benítez, D de Gonzalo-Calvo, G Torres, J de Batlle, ... Critical Care 26, 1-11, 2022 | 47 | 2022 |
| ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations AG Mathioudakis, F Abroug, A Agusti, S Ananth, P Bakke, K Bartziokas, ... European Respiratory Journal 59 (5), 2022 | 47 | 2022 |
Òscar MiróConsultant. Emergency Department. Researcher. Hospital Clínic, IDIBAPS. Barcelona, CATALONIA (Spain)在 clinic.cat 的电子邮件经过验证
